4.7 Article

Parental Understanding of Newborn Screening for Cystic Fibrosis After a Negative Sweat-Test

期刊

PEDIATRICS
卷 127, 期 2, 页码 276-283

出版社

AMER ACAD PEDIATRICS
DOI: 10.1542/peds.2010-2284

关键词

cystic fibrosis; false-positive; newborn screening; genetic counseling; genetic testing; heterozygote detection; residual risk; sweat test; anxiety

资金

  1. Illinois Department of Public Health

向作者/读者索取更多资源

BACKGROUND: Newborn screening for cystic fibrosis (CF) in Illinois uses an immunoreactive trypsinogen/DNA methodology; most false-positive results identify unaffected carriers. METHODS: Parents whose child received a negative result from the sweat test after a positive newborn screening for CF were surveyed >= 6 weeks later by telephone. All parents received genetic counseling while waiting for the sweat-test results. RESULTS: A total of 90 parents participated. Overall knowledge of CF was high (78%), but the ability to understand the CF screening results was mixed. Although 94% of the parents understood that their child did not have CF, only 79% (62 of 78) of participants whose child had a mutation knew their child was definitely a carrier, and only 1 of 12 parents whose child had no mutation understood that the child may be a carrier. Respondents stated that most relatives were not interested in genetic testing. Both parents had been tested in only 13 couples. Fewer than half (36 of 77 [47%]) of the untested couples expressed interest in genetic testing. Although most participants were satisfied with the process, parents expressed frustration because of the lack of prospective newborn screening discussions by prenatal and pediatric providers and lack of knowledge and sensitivity by those who initially notified them of the abnormal newborn screening results. Speaking to a genetic counselor when scheduling the sweat test decreased anxiety for many parents (53 of 73 [73%] were very worried at notification versus 18 of 73 [25%] after scheduling; P < .001). CONCLUSIONS: Parental knowledge about CF is high, but confusion about the child's carrier status and the concept of residual risk persist despite genetic counseling. Relatives express low interest in carrier testing. Pediatrics 2011;127:276-283

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Respiratory System

Predicting the course of nutrition and lung disease in infants and children with cystic fibrosis

Susanna A. McColley

JOURNAL OF CYSTIC FIBROSIS (2020)

Review Pediatrics

Cystic fibrosis year in review 2019: Section 2 pulmonary disease and infections

Adrienne P. Savant, Susanna A. McColley

Summary: This article reviews the research and case reports in the field of cystic fibrosis (CF) during 2019, with a specific focus on new research related to pulmonary disease and infections. It is an important resource for healthcare providers caring for CF patients.

PEDIATRIC PULMONOLOGY (2023)

Review Pediatrics

Cystic fibrosis year in review 2019: Section 3 multisystem-based care and research

Adrienne P. Savant, Susanna A. McColley

Summary: This report focuses on the multisystem manifestations of cystic fibrosis (CF) care, discussing various research studies and reports published in 2019. It highlights the importance of providing improved care for CF patients and their families and the exciting opportunities for involvement in this field.

PEDIATRIC PULMONOLOGY (2023)

Article Pediatrics

Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype

Meghan E. McGarry, Susanna A. McColley

Summary: This study found that minority groups of cystic fibrosis patients are less likely to be eligible for CFTR modulator therapy, potentially leading to increased disease severity and earlier mortality. This will further contribute to health disparities among people with cystic fibrosis.

PEDIATRIC PULMONOLOGY (2021)

Article Pediatrics

Preferences for disclosing adverse childhood experiences for children and adults with cystic fibrosis

Wadsworth A. Williams, Manu Jain, Theresa A. Laguna, Susanna A. McColley

Summary: The survey found that the majority of parents and adults with CF were more willing to disclose the number of categorical ACEs experienced, and were willing to participate in anonymous research. Most participants preferred to have ACE screening separate from CF appointments and wanted to learn more about ACEs from their care team members.

PEDIATRIC PULMONOLOGY (2021)

Article Pediatrics

Outcomes of infants born during the first 9 years of CF newborn screening in the United States: A retrospective Cystic Fibrosis Foundation Patient Registry cohort study

Stacey L. Martiniano, Alexander A. Elbert, Philip M. Farrell, Clement L. Ren, Marci K. Sontag, Runyu Wu, Susanna A. McColley

Summary: During 9 years of CF NBS, the median age at first CF event decreased. CF NBS had positive health impacts, but early life nutritional deficits and a high rate of infant hospitalizations persist.

PEDIATRIC PULMONOLOGY (2021)

Letter Pediatrics

A rare case of pancytopenia in a child with cystic fibrosis: Can copper cure it all?

Maggie D. Seblani, Susanna A. McColley, Shunyou Gong, Lee M. Bass, Sherif M. Badawy

PEDIATRIC PULMONOLOGY (2022)

Article Critical Care Medicine

A Phase 3, Open-Label Study of Lumacaftor/Ivacaftor in Children 1 to Less Than 2 Years of Age with Cystic Fibrosis Homozygous for F508del-CFTR

Jonathan H. Rayment, Fadi Asfour, Margaret Rosenfeld, Mark Higgins, Lingyun Liu, Molly Mascia, Hildegarde Paz-Diaz, Simon Tian, Rachel Zahigian, Susanna A. McColley

Summary: The study evaluated the safety, pharmacokinetics, and pharmacodynamics of lumacaftor/ivacaftor in children aged 1 to <2 years with the F/F genotype. The results showed that the treatment was generally safe and well tolerated, with potential for CF disease modification indicated by significant reductions in sweat chloride concentration. Efficacy results supported the use of lumacaftor/ivacaftor in this population.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Article Respiratory System

Disparities in first evaluation of infants with cystic fibrosis since implementation of newborn screening

Susanna A. McColley, Stacey L. Martiniano, Clement L. Ren, Marci K. Sontag, Karen Rychlik, Lauren Balmert, Alexander Elbert, Runyu Wu, Philip M. Farrell

Summary: This study evaluated whether the implementation of cystic fibrosis newborn screening leads to equitable timeliness of initial evaluation. The study compared the age at the first event (AFE) between infants of different races and ethnicities (Group 1) and white non-Hispanic infants (Group 2). The study found that differences in AFE for infants with CF from historically marginalized groups may exacerbate long-standing health disparities.

JOURNAL OF CYSTIC FIBROSIS (2023)

Letter Pediatrics

Editor's response to An oversight regarding the club cell?

Susanna A. McColley

PEDIATRIC PULMONOLOGY (2022)

Article Pediatrics

Detection of disease-causing CFTR variants in state newborn screening programs

Meghan E. McGarry, Clement L. Ren, Runyu Wu, Philip M. Farrell, Susanna A. McColley

Summary: This study aims to explore the differences in detection rates of CFTR variant panels among different races and ethnicities. It was found that minority racial and ethnic groups have lower detection rates, leading to false-negative newborn screening and delayed diagnoses.

PEDIATRIC PULMONOLOGY (2023)

Letter Cardiac & Cardiovascular Systems

In response to who are the 10%? - Non eligibility of cystic fibrosis (CF) patients for highly effective modulator therapies

Meghan E. McGarry, Susanna A. McColley, Jennifer Taylor-Cousar

RESPIRATORY MEDICINE (2022)

Article Medicine, Research & Experimental

Barriers and facilitators to recruitment of underrepresented research participants: Perspectives of clinical research coordinators

Marie E. Heffernan, Leo Barrera, Zecilly R. Guzman, Emily Golbeck, Aneta M. Jedraszko, P. Toddie Hays, Keith A. Herzog, Richard T. D'Aquila, Michael G. Ison, Susanna A. Mccolley

Summary: The study examined barriers and facilitators to recruiting underrepresented research participants in medical research, finding that providing translated materials, incentives, and reducing in-person visits can improve recruitment. Cultural competency training may need further research on its impact.

JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE (2023)

Article Medicine, Research & Experimental

Anti-racist strategies for clinical and translational research: Design, implementation, and lessons learned from a new course

Nia J. Heard-Garris, Jen F. Brown, Uchenna C. Ewulonu, Mita S. Goel, Adam S. Gordon, Candace Henley, Sadiya S. Khan, Shawn M. Smith, Susanna A. McColley

Summary: This article presents a course designed to teach anti-racist research design and discusses its positive impact on students' research approaches.

JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE (2022)

Article Genetics & Heredity

Newborn Screening for Cystic Fibrosis: A Qualitative Study of Successes and Challenges from Universal Screening in the United States

Marci K. Sontag, Joshua Miller, Sarah McKasson, Amy Gaviglio, Stacey L. Martiniano, Rhonda West, Marisol Vazquez, Clement L. Ren, Philip M. Farrell, Susanna A. McColley, Yvonne Kellar-Guenther

Summary: Cystic fibrosis newborn screening (NBS) implementation in the United States has led to variations in diagnosis and intervention timing, with challenges including communication difficulties between healthcare providers and families, and misconceptions about clinical risk in infants from ethnic minority groups. However, there is a strong relationship between NBSP and CF centers, and early diagnosis can be facilitated through increased engagement with healthcare providers.

INTERNATIONAL JOURNAL OF NEONATAL SCREENING (2022)

暂无数据